VANTAGE CONSULTING GROUP INC – Pfizer Inc. Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$235,000
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
-16.54%
quarter
Pfizer Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +11.55% | 556 shares | -17K | $43.76 | 5.36K |
Q2 2022 | share | Increase | +5.36% | 245 shares | 16K | $52.43 | 4.81K |
Q1 2022 | share | Decrease | -7.23% | -356 shares | -55K | $51.77 | 4.56K |
Q4 2021 | share | Decrease | -7.91% | -423 shares | 61K | $58.4 | 4.92K |
Q3 2021 | share | Decrease | -5.06% | -285 shares | 9K | $42.63 | 5.34K |
Q2 2021 | share | Increase | 0.00% | 5.63K shares | 221K | $38.46 | 5.63K |
Q1 2021 | share | Decrease | -100.00% | -1.77K shares | -65K | $35.24 | 0 |